S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NYSE:CO

Global Cord Blood Stock Forecast, Price & News

$3.94
+0.02 (+0.51 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.84
Now: $3.94
$3.96
50-Day Range
$3.55
MA: $3.84
$4.12
52-Week Range
$2.54
Now: $3.94
$5.10
Volume78,800 shs
Average Volume209,021 shs
Market Capitalization$478.91 million
P/E Ratio6.68
Dividend YieldN/A
Beta0.39
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Global Cord Blood logo

MarketRank

Overall MarketRank

0.90 out of 5 stars

Medical Sector

1054th out of 1,923 stocks

Holding & Other Investment Offices Industry

30th out of 204 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone852-3605-8180
Employees1,260

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$172.50 million
Cash Flow$0.60 per share
Book Value$4.52 per share

Profitability

Net Income$66.48 million

Miscellaneous

Market Cap$478.91 million
Next Earnings Date3/10/2021 (Estimated)
OptionableOptionable
$3.94
+0.02 (+0.51 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Global Cord Blood (NYSE:CO) Frequently Asked Questions

How has Global Cord Blood's stock price been impacted by COVID-19?

Global Cord Blood's stock was trading at $4.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CO shares have decreased by 3.2% and is now trading at $3.94.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Global Cord Blood?

Wall Street analysts have given Global Cord Blood a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Global Cord Blood wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Global Cord Blood's next earnings date?

Global Cord Blood is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Global Cord Blood
.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) posted its quarterly earnings data on Tuesday, November, 24th. The medical research company reported $0.16 earnings per share for the quarter. The medical research company had revenue of $42.07 million for the quarter. Global Cord Blood had a net margin of 42.17% and a trailing twelve-month return on equity of 12.77%.
View Global Cord Blood's earnings history
.

Who are some of Global Cord Blood's key competitors?

What other stocks do shareholders of Global Cord Blood own?

Who are Global Cord Blood's key executives?

Global Cord Blood's management team includes the following people:
  • Ms. Ting Zheng, Chairperson , CEO & CEO of Beijing Division (Age 49, Pay $1.03M)
  • Mr. Bing Chuen Chen CFA, CFO & Director (Age 45, Pay $976.87k)
  • Ms. Xin Xu, Chief Technology Officer (Age 67, Pay $131.39k)
  • Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong & Zhejiang Divisions (Age 62, Pay $258.28k)
  • Ms. Cathy Bai, VP of Corp. Fin.

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How do I buy shares of Global Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $3.94.

How big of a company is Global Cord Blood?

Global Cord Blood has a market capitalization of $478.91 million and generates $172.50 million in revenue each year. Global Cord Blood employs 1,260 workers across the globe.

What is Global Cord Blood's official website?

The official website for Global Cord Blood is www.globalcordbloodcorp.com.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.